Chungcheongbuk-do, South Korea

Han-Saem Lee

This inventor holds 1 USPTO granted patent. Top assignees: Celltrion Inc., Korea Disease Control and Prevention Agency. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Han-Saem Lee. Retrieved from https://idiyas.com/inventor/han-saem-lee-vi70kpg6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Han-Saem Lee: Innovator in SARS-CoV-2 Neutralization

Introduction

Han-Saem Lee is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the fight against viral infections. His work focuses on developing innovative solutions to combat the SARS-coronavirus-2, the virus responsible for COVID-19.

Latest Patents

Han-Saem Lee holds a patent for a binding molecule that exhibits neutralizing activity against SARS-coronavirus-2. This invention relates to a binding molecule that specifically targets the spike protein (S protein) on the surface of the virus. The binding molecule demonstrates a strong ability to bind to SARS-CoV-2 and possesses high neutralizing activity, making it a valuable tool for the diagnosis, prevention, or treatment of SARS-coronavirus infection.

Career Highlights

Throughout his career, Han-Saem Lee has worked with prominent organizations such as the Korea Disease Control and Prevention Agency and Celltrion Inc. His experience in these institutions has allowed him to contribute to significant advancements in public health and biotechnology.

Collaborations

Han-Saem Lee has collaborated with esteemed colleagues, including Kyung-Chang Kim and Jun-Won Kim. Their joint efforts have furthered research and development in the field of viral neutralization.

Conclusion

Han-Saem Lee's innovative work in developing a binding molecule against SARS-CoV-2 highlights his commitment to advancing medical science. His contributions are crucial in the ongoing battle against COVID-19 and demonstrate the importance of innovation in public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…